Search Results - Alan Oglesby

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Relationship of Glycemic Control to Total Diabetes-Related Costs for Managed Care Health Plan Members With Type 2 Diabetes

    Relationship of Glycemic Control to Total Diabetes-Related Costs for Managed Care Health Plan Members With Type 2 Diabetes by Sharashchandra Shetty, Kristina Secnik, Alan Oglesby

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Predicted Costs and Outcomes From Reduced Vibration Detection in People With Diabetes in the U.S.

    Predicted Costs and Outcomes From Reduced Vibration Detection in People With Diabetes in the U.S. by Arran Shearer, Paul Scuffham, Adam Gordois, Alan Oglesby

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.

    The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S. by Adam Gordois, Paul Scuffham, Arran Shearer, Alan Oglesby, Janet Tobian

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The association between diabetes related medical costs and glycemic control: A retrospective analysis

    The association between diabetes related medical costs and glycemic control: A retrospective analysis by Alan Oglesby, Kristina Secnik, John Barron, Ibrahim Al‐Zakwani, Maureen J. Lage

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain

    The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain by Rhys Pockett, Daniel Castellano, Phil McEwan, Alan Oglesby, BL Barber, Karen Chung

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes

    Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes by Kristina S. Boye, Louis S. Matza, Alan Oglesby, Karen G. Malley, Sunny Kim, Risa P. Hayes, Robert G. Brodows

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Optimization of BMD Measurements to Identify High Risk Groups for Treatment—A Test Analysis

    Optimization of BMD Measurements to Identify High Risk Groups for Treatment—A Test Analysis by Helena Johansson, Anders Odén, Olof Johnell, Bengt Jönsson, Chris De Laet, Alan Oglesby, Eugène McCloskey, Karthik Kayan, T. Jalava, John А. Kanis

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study

    Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study by Princy Kumar, Amanda Clarke, Celia Jonsson‐Oldenbüttel, Miguel García Deltoro, Simona Di Giambenedetto, Carlos Brites, Laurent Hocqueloux, Po‐Liang Lu, J Oyee, Alan Oglesby, Brian Wynne, Bryn Jones, Lee Evitt, Dainielle Fox, Michelle Kisare, Julie Priest

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: